Pouliot M C, Després J P, Dionne F T, Vohl M C, Moorjani S, Prud'homme D, Bouchard C, Lupien P J
Lipid Research Center, CHUL, Ste-Foy, Québec, Canada.
Arterioscler Thromb. 1994 Apr;14(4):527-33. doi: 10.1161/01.atv.14.4.527.
The aim of this study was to investigate whether the EcoRI restriction fragment length polymorphism (RFLP) of the apolipoprotein (apo) B-100 gene influences the associations described among obesity, regional adipose tissue distribution, and plasma lipoprotein levels. For this purpose, blood samples were collected from 56 healthy men for whom we had extensive measurements of regional adipose tissue distribution (both anthropometric and computed tomography-derived measurements) and data on the plasma lipoprotein-lipid profile. DNA was extracted from white blood cells, and RFLP analysis was performed. Subjects were classified into two groups on the basis of their apoB-100 EcoRI genotype: subjects homozygous for the major 11-kb allele, the 11/11 group (n = 40), and subjects carrying the minor 13-kb allele, the 13/11 group (n = 16). Subjects carrying the 13-kb allele had lower percent body fat and abdominal adipose tissue accumulation than subjects homozygous for the 11-kb allele (P < .05). Although leaner, the 13/11 group did not show a more favorable plasma lipoprotein-lipid profile than the group homozygous for the 11-kb allele. In fact, after statistical control for the difference in percent body fat between the two genotype groups, the 13/11 group showed significantly higher plasma cholesterol levels (P < .05) and nearly significantly higher apoB levels than the 11/11 group (P = .06). The association patterns between indices of regional adiposity and plasma cholesterol and apoB levels were also different between the two EcoRI genotype groups. Only in the 13/11 group was the abdominal visceral adipose tissue area significantly associated with these plasma variables.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是调查载脂蛋白(apo)B - 100基因的EcoRI限制性片段长度多态性(RFLP)是否会影响肥胖、局部脂肪组织分布和血浆脂蛋白水平之间所描述的关联。为此,我们从56名健康男性中采集了血样,这些男性有关于局部脂肪组织分布的广泛测量数据(包括人体测量和计算机断层扫描得出的测量数据)以及血浆脂蛋白 - 脂质谱数据。从白细胞中提取DNA,并进行RFLP分析。根据apoB - 100 EcoRI基因型将受试者分为两组:主要11 kb等位基因的纯合子受试者,即11/11组(n = 40),以及携带次要13 kb等位基因的受试者,即13/11组(n = 16)。携带13 kb等位基因的受试者比11 kb等位基因纯合子受试者的体脂百分比和腹部脂肪组织蓄积更低(P <.05)。尽管13/11组更瘦,但与11 kb等位基因纯合子组相比,其血浆脂蛋白 - 脂质谱并未更有利。实际上,在对两个基因型组之间的体脂百分比差异进行统计学控制后,13/11组的血浆胆固醇水平显著更高(P <.05),apoB水平比11/11组几乎显著更高(P = 0.06)。两个EcoRI基因型组之间局部肥胖指数与血浆胆固醇和apoB水平之间的关联模式也不同。仅在13/11组中,腹部内脏脂肪组织面积与这些血浆变量显著相关。(摘要截短于250字)